BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Alcobra 

35 Ehad Ha-Am Street

  Tel-Aviv  65202   Israel
Phone: n/a Fax: n/a


SEARCH JOBS








 Company News
Alcobra (ADHD) Submits Protocol To FDA For Phase 2b Clinical Study Of Metadoxine Extended Release (MDX) In The Treatment Of Fragile X Syndrome 4/10/2014 3:05:18 PM    More...
Alcobra (ADHD) Announces Shares Uplisted To NASDAQ Global Market 3/26/2014 9:26:18 AM    More...
Alcobra (ADHD) Announces Enrollment Of First Patient In Phase 3 Clinical Trial For MDX In Adult ADHD 3/18/2014 9:14:39 AM    More...
Alcobra (ADHD) Announces FDA Clearance Of IND For Metadoxine Extended Release (MDX) 3/6/2014 9:22:11 AM    More...
Alcobra (ADHD) To Discuss Biomarkers In Fragile X And Autism Trials At The Second Annual Autism Investment Conference 2/24/2014 8:50:23 AM    More...
Alcobra (ADHD) Appoints J.P. Morgan Banker Dr. Tomer Berkovitz As Chief Financial Officer 2/19/2014 8:55:20 AM    More...
Alcobra (ADHD) To Provide Corporate Overview At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 1/31/2014 9:10:23 AM    More...
Alcobra (ADHD) To Release Fourth Quarter 2013 Results And Host Investor Conference Call On Thursday, February 13, 2014 1/29/2014 8:52:18 AM    More...
Alcobra (ADHD) Announces New Biomarker Finding In A Follow-Up Fragile X Animal Study For MG01CI 1/27/2014 8:53:54 AM    More...
Alcobra (ADHD) Strengthens Management Team With Addition Of Industry Veteran David C. Baker As Chief Commercial Officer 1/13/2014 9:35:39 AM    More...
12

//-->